Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 13-24 of 602
» View wsbtradio.com items only
    May 18, 2013 |Story| Hartford Courant
  1. Misdiagnosis: More Common Than Drug Errors or Wrong-Site Surgery

    The Hartford Courant
    Until it happened to him, Itzhak Brook, a pediatric infectious disease specialist at Georgetown University School of Medicine, didn't think much about the problem of misdiagnosis. That was before doctors at a Maryland hospital repeatedly told Brook his...

    Tags: Heart Failure, Heart Attack, Internists, U.S. Department of Veterans Affairs, Corporate Officers

  2. May 16, 2013 |Story| Reuters
  3. CORRECTED-Data show new Roche leukemia drug may improve on Rituxan

    Reuters
    (Corrects paragraph 12 to show Biogen has stake in new drug) By Bill Berkrot May 15 (Reuters) - An experimental leukemia treatment that Roche Holding AG hopes will improve upon its best-selling cancer drug Rituxan delayed disease progression twice as...

    Tags: Heart Disease, Diseases and Illnesses, Cancer, Health Treatments, Leukemia

  4. May 16, 2013 |Story| Allentown Morning Call
  5. Lehigh Valley company news

    Samuel Adams partners withRising Tide Community Loan fund The Boston Beer Co., in partnership with Accion, announced that its Samuel Adams Brewing the American Dream program has teamed up with the Rising Tide Community Loan Fund, a nonprofit micro-lender...

    Tags: Business, Boston Beer Company Inc., Small Businesses, Medical Research, Renal cell carcinoma

  6. May 16, 2013 |Story| Reuters
  7. AstraZeneca accelerates cancer drug testing

    Reuters
    LONDON (Reuters) - AstraZeneca has enrolled the first patient into a final-stage clinical trial of a new drug for a rare type of leukemia as the group's new CEO delivers on a promise to accelerate its oncology programs. Britain's second-biggest drugmaker...

    Tags: Ovarian Cancer, Drugs and Medicines, Medical Specialization, Lung Cancer, Trials

  8. May 18, 2013 |Story| Allentown Morning Call
  9. Angelina Jolie's decision to get double mastectomy isn't unusual in Lehigh Valley

    Kelly Vanek, a runner, cyclist and triathlete, was listening to sports talk radio in the car when the conversation shifted to Angelina Jolie.
    Kelly Vanek, a runner, cyclist and triathlete, was listening to sports talk radio in the car when the conversation shifted to Angelina Jolie. The actress and sex symbol took the public by surprise last week with the announcement that she had her healthy...

    Tags: Ovarian Cancer, Pancreatic Cancer, Diseases and Illnesses, Medical Specialization, Cancer

  10. May 10, 2013 |Story| Los Angeles Times
  11. Patient is out of network, out of luck

    A worrisome abdominal pain drove Jalal Afshar to seek treatment last year at healthcare giant Kaiser Permanente.
    A worrisome abdominal pain drove Jalal Afshar to seek treatment last year at healthcare giant Kaiser Permanente. The Pasadena resident and Kaiser member had lived for years with a rare condition known as Castleman's disease, which affects the lymph...

    Tags: Health and Safety at School, Medical Procedures and Tests, Breach of Contract, City of Hope, Abdominal Pain

  12. May 15, 2013 |Story| Reuters
  13. Ovarian cancer fall sped up as hormone use dropped

    Reuters
    NEW YORK (Reuters Health) - Ovarian cancer rates in the U.S. began to decline faster in 2002 around the time many older women went off hormone replacement therapy, according to a new study. That year, the Women's Health Initiative (WHI) found that...

    Tags: Heart Disease, Ovarian Cancer, Heart Attack, Medical Specialization, Bethesda (Montgomery, Maryland)

  14. May 15, 2013 |Story| Reuters
  15. Bristol-Myers shares jump ahead of melanoma trial data

    Reuters
    CHICAGO/NEW YORK (Reuters) - Shares of drugmaker Bristol-Myers Squibb Co rose to a 10-year high on Wednesday ahead of results of an early stage trial for its new melanoma treatment, with heavy betting in the options market suggesting investors see more...

    Tags: Bristol Myers Squibb Company, Annual and Special Corporate Meetings, Skin Cancer

  16. May 15, 2013 |Story| Reuters
  17. Bristol melanoma drug combo marks new advance in immunotherapy

    Reuters
    (For more stories on new cancer data, see ) By Julie Steenhuysen CHICAGO, May 15 (Reuters) - Melanoma patients treated with two Bristol-Myers Squibb drugs fared much better than those who received either of the medications individually, a new advance...

    Tags: GlaxoSmithKline PLC, Merck & Company Incorporated, Medical Specialization, Lung Cancer, Food and Drug Administration

  18. May 15, 2013 |Story| Reuters
  19. New cancer tools allow patients to reconsider chemo

    Reuters
    By Deena Beasley LOS ANGELES, May 15 (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh treatments. An approach to oncology...

    Tags: Customs and Tradition, Lymphoma, Cancer, Mastectomy, Medical Procedures and Tests

  20. May 15, 2013 |Story| Reuters
  21. Roche immunotherapy shows response over range of cancers

    Reuters
    By Bill Berkrot May 15 (Reuters) - An experimental Roche Holding AG drug that helps the immune system attack tumors was well tolerated and demonstrated an impressive effect against a variety of cancers, according to preliminary trial results released on...

    Tags: Merck & Company Incorporated, New Haven (New Haven, Connecticut), Medical Specialization, Litigation, Lung Cancer

  22. May 15, 2013 |Story| Reuters
  23. Experimental Gilead drug effective in early-stage leukemia trial

    Reuters
    By Deena Beasley May 15 (Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into oncology by the world's biggest...

    Tags: Gilead Sciences Inc., National Hockey League, Diseases and Illnesses, Dana-Farber Cancer Institute, Medical Specialization

< Previous1  2  3 4 5 6 7 8 9 10 11-51Next >
Original site for Oncology topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Oncology Photos
Dr. Ijaz I. Arshad, medical director of the Cancer Inst...
(May 15, 2013)
Dr. Ijaz I. Arshad
Colleen Kisel of the Pediatric Oncology Treasure Chest...
(April 26, 2013)
Colleen Kisel of the Pediatric Oncology Treasure Chest Foundation
Dr. Margo Shoup, M.D., has been appointed medical leade...
(February 12, 2013)
Dr. Margo Shoup, cancer program medical leader, Cadence Health